Morepen Laboratories Ltd — Quarterly Results & Earnings

₹33.68

-2.22%

Profit Growth YoY-49.02%Latest quarter

Sales Growth YoY-5.97%Latest quarter

Sales CAGR 5Y16.26%5 year compound

Profit CAGR 5Y28.58%5 year compound

📋

Quarterly Performance

YoY Profit Growth-49.02%

🔴 Significant decline

YoY Sales Growth-5.97%

⚠️ Mild contraction

OPM 5Y Average

Operating profit margin

8.72%

EPS Growth 5Y

23.60%

Interest Coverage

Higher = safer debt servicing

7.77

ROE

11.78%

ROCE

15.08%

💡

Growth Analysis

Morepen Laboratories Ltd reported YoY profit growth of -49.02% and revenue growth of -5.97% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 16.26% and profits at 28.58% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Morepen Laboratories Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.